Bhunchet E, Eishi Y, Wake K
Department of Pathology, School of Medicine, Tokyo Medical and Dental University, Japan.
Hepatology. 1996 Apr;23(4):811-7. doi: 10.1053/jhep.1996.v23.pm0008666336.
To investigate whether hepatic fibrosis induced by porcine serum in rats is caused by an immune reaction to porcine serum, rats that were immunologically tolerant exclusively to porcine serum were subjected to the repeated injection of porcine serum over a long period. This porcine serum-tolerant group consisted of 15 Wistar rats that had been injected intraperitoneally with porcine serum twice a week from the first postnatal day for 18 weeks. The control group consisted of 16 Wistar rats, aged 8 weeks, that were injected intraperitoneally with porcine serum twice a week for 10 weeks. Livers were fixed and examined by light microscopy. The serum of each rat was subjected to indirect enzyme-linked immunosorbent assay (ELISA) to measure the level of antibody to porcine albumin. In addition, immunohistochemical staining for ED1 was performed on untreated normal and porcine serum-induced fibrotic rat livers to examine the distribution of macrophages and their precursors, the monocytes. All rats in the tolerant group showed an extremely low antibody level (x = 68.27 +/- 4.53), and none (0/15) developed hepatic fibrosis. The majority of rats in the control group showed a very high antibody level (x = 1242.19 +/- 201.15); 75 percent (12/16) developed hepatic fibrosis. Data indicate that, despite the prolonged, repeated injections of porcine serum, if an immune response to porcine serum does not occur, the rats do not develop hepatic fibrosis. The porcine serum-tolerant rats developed hepatic fibrosis after 4 weeks of CCl4 treatment, indicating that injection of porcine serum into neonatal rats did not cause anergy of fibrogenesis, thereby preventing the animal from developing hepatic fibrosis. In normal rat liver, ED1-positive cells, which include nearly all Kupffer cells, were located pre-dominantly in the periportal area. In fibrotic rat liver, ED1-positive cells aggregated prominently in the newly formed and advanced connective tissue septa developed mainly between the neighboring central veins, and in fibrotic parts of the liver capsule. Aggregation of ED1-positive cells was rarely observed in nonfibrotic parts of the liver capsule. The difference between normal and fibrotic rat liver in distribution of EDl-positive cells suggests an involvement of macrophages in fibrogenesis and septum formation. In conclusion, our study showed a significant contribution by the immune response to porcine serum antigens leading to porcine serum-induced rat hepatic fibrosis--processes in which macrophages may be important. This study may lead to an understanding of the mechanism responsible for this form of experimental hepatic fibrosis.
为研究大鼠中猪血清诱导的肝纤维化是否由对猪血清的免疫反应所致,对仅对猪血清产生免疫耐受的大鼠进行长期反复注射猪血清。该猪血清耐受组由15只Wistar大鼠组成,从出生后第一天开始每周两次腹腔注射猪血清,持续18周。对照组由16只8周龄的Wistar大鼠组成,每周两次腹腔注射猪血清,持续10周。将肝脏固定并进行光学显微镜检查。对每只大鼠的血清进行间接酶联免疫吸附测定(ELISA)以测量抗猪白蛋白抗体水平。此外,对未经处理的正常大鼠肝脏和猪血清诱导的纤维化大鼠肝脏进行ED1免疫组化染色,以检查巨噬细胞及其前体单核细胞的分布。耐受组的所有大鼠抗体水平极低(x = 68.27 +/- 4.53),且无一(0/15)发生肝纤维化。对照组的大多数大鼠抗体水平非常高(x = 1242.19 +/- 201.15);75%(12/16)发生肝纤维化。数据表明,尽管长期反复注射猪血清,但如果对猪血清未发生免疫反应,大鼠不会发生肝纤维化。猪血清耐受大鼠在四氯化碳处理4周后发生肝纤维化,这表明向新生大鼠注射猪血清不会导致纤维生成无反应,从而防止动物发生肝纤维化。在正常大鼠肝脏中,几乎包括所有枯否细胞的ED1阳性细胞主要位于汇管区周围。在纤维化大鼠肝脏中,ED1阳性细胞主要在相邻中央静脉之间新形成的和进展期的结缔组织间隔中以及肝包膜的纤维化部分显著聚集。在肝包膜的非纤维化部分很少观察到ED1阳性细胞聚集。正常和纤维化大鼠肝脏中ED1阳性细胞分布的差异表明巨噬细胞参与了纤维生成和间隔形成。总之,我们的研究表明对猪血清抗原的免疫反应对猪血清诱导的大鼠肝纤维化有显著作用——巨噬细胞可能在这些过程中起重要作用。该研究可能有助于理解这种形式的实验性肝纤维化的机制。